Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis

Ferroptosis inducers for prostate cancer therapy

(2022) Nadia Zaffaroni et al.   CURRENT MEDICINAL CHEMISTRY

Targeting the androgen receptor signaling pathway in advanced prostate cancer

(2022) Clement Chung et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth

(2022) Sheng Zhan et al.   BRITISH JOURNAL OF CANCER

Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming

(2022) Meng-Ting Chang et al.   PHARMACOLOGICAL RESEARCH

Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation

(2022) Wenchang Yang et al.   Frontiers in Pharmacology

Molecular mechanisms of reactive oxygen species in regulated cell deaths: Impact of ferroptosis in cancer therapy

(2022) Morteza Golbashirzadeh et al.   Gene Reports

Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis

(2022) Zhibin Yang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Second generation androgen receptor antagonists and challenges in prostate cancer treatment

(2022) Yanhua Chen et al.   Cell Death & Disease

Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma

(2022) Xiaofeng Kang et al.   Frontiers in Oncology

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

(2022) Mamello Sekhoacha et al.   MOLECULES

Overexpression of LncRNA MNX1-AS1/PPFIA4 Activates AKT/HIF-1α Signal Pathway to Promote Stemness of Colorectal Adenocarcinoma Cells

(2022) Qi Sun et al.   Journal of Oncology

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer

(2022) Govinda Nanjaiah Laxmana Raju et al.   Journal of Laboratory Physicians

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis

(2021) Ke Ren et al.   Frontiers in Oncology

A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer

(2021) Daniel Westaby et al.   Annual Review of Pharmacology and Toxicology

LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC

(2021) Yantao Liu et al.   Cancer Cell International

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

(2021) Aasems Jacob et al.   Cancers

Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation

(2020) Lian‐Dong Shen et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib

(2020) Xiang Song et al.   Frontiers in Oncology

LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2

(2019) Na Huang et al.   Frontiers in Oncology

Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1

(2018) Xiaowei Diao et al.   ONCOLOGY REPORTS

The Diagnosis and Treatment of Prostate Cancer

(2017) Mark S. Litwin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer

(2016) Marcella Bassetto et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer

(2014) Antoine Angelergues et al.   EUROPEAN JOURNAL OF CANCER

Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1α

(2014) Wei Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site

(2013) Kurtis Eisermann et al.   Molecular Cancer

Overcoming Drug Resistance and Treating Advanced Prostate Cancer

(2012) Julius Semenas et al.   CURRENT DRUG TARGETS

Suppression of the androgen receptor function by quercetin through protein–protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells

(2010) Huiqing Yuan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY